Key result
Preexisting coagulopathy linked to ~450% higher MACCE risk after female pelvic reconstructive surgery.
Why the study?
The study was conducted to evaluate national trends in major adverse cardiovascular and cerebrovascular events in female pelvic reconstructive surgery.
What is the incidence and what are the risk factors for major adverse cardiovascular and cerebrovascular events in women undergoing female pelvic reconstructive surgery?
Observational (n=53,540)
Yes
What is the incidence and what are the risk factors for major adverse cardiovascular and cerebrovascular events in women undergoing female pelvic reconstructive surgery?
Major adverse cardiovascular and cerebrovascular events after female pelvic reconstructive surgery are rare (4.8 per 1000), but risk is significantly increased in patients with preexisting coagulopathy, heart failure, neurologic disease, and those requiring perioperative blood transfusions.
Answers are grounded in this paper and cite their sources.
May prompt closer monitoring for coagulopathy in pelvic reconstructive surgery; leaves open whether mitigation reduces MACCE.
OBJECTIVE: To evaluate national trends in major adverse cardiovascular and cerebrovascular events (MACCE) in female pelvic reconstructive surgery (FPRS). METHODS: Data from the National Inpatient Sample was used to identify women undergoing FPRS between 2012 and 2016. Demographic, procedural, and comorbidity data were collected. Patients were stratified into those with and without MACCE (defined as all-cause mortality, cardiac arrest, myocardial infarction (MI) and acute ischemic stroke). Descriptive statistics are expressed as medians and interquartile ranges. Pairwise analysis was performed using Wilcoxon rank-sum or Fisher exact test as appropriate. Multivariable logistic regression was used to identify independent risk factors for MACCE. RESULTS: During the study period, 53,540 patients underwent FPRS. The rate of MACCE was 4.8 per 1000 surgeries; MI, 3.7; acute ischemic stroke, 0.6; cardiac arrest, 0.4; and all-cause mortality, 0.3. Patients experiencing MACCE were more likely to have major preexisting cardiovascular comorbidities, coagulopathy, neurologic disease (ND), and diabetes and were more likely to undergo robotic colpopexy (20.7% vs 9.6%, P < 0.001), vaginal colpopexy (32.0% vs 28.5%, P = 0.04), and to receive a blood transfusion (8.2% vs 2.5%, P < 0.001).On logistic regression, preexisting coagulopathy was the strongest predictor of MACCE (adjusted odds ratio [aOR], 5.53; 95% confidence interval [CI], 2.39-12.78), followed by blood transfusion (aOR, 4.84; 95% CI, 1.89-12.45), congestive heart failure (aOR, 3.61; 95% CI, 1.56-8.37), ND (aOR, 3.14; 95% CI, 1.23-8.06), and electrolyte abnormalities (aOR, 1.99; 95% CI, 1.05-3.99). CONCLUSION: Major adverse cardiovascular and cerebrovascular events after FPRS is a rare event, with MI being the most common manifestation. Preexisting ND, congestive heart failure, coagulopathy, electrolyte disturbances, and perioperative transfusions are strongly associated with MACCE.
No takes yet. Share an insight, caveat, or question.
Roberts et al. (2020) conducted an observational in Female pelvic reconstructive surgery (n=53,540). Preexisting coagulopathy vs. Without preexisting coagulopathy was evaluated on Major adverse cardiovascular and cerebrovascular events (MACCE) (aOR 5.53, 95% CI 2.39-12.78). Preexisting coagulopathy was the strongest predictor of major adverse cardiovascular and cerebrovascular events after female pelvic reconstructive surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: